Home / Taiwan Excellence Award / Award Winning Products / Product Details

“RevoCart” One-step Autologous Cartilage Repair System
Industry type:Health and precision instrument
Product model number:3RC002M
award 3

The information related to this product could not be shown due to medical law, please contact the company directly for more information.


Contact online


BioGend Therapeutics was established in July 2016 with a noble vision to be an innovative solutions provider for holistic medical care to restore bone and joint functions. We are committed to develop regenerative orthobiologic products that fulfill unmet clinical needs. We strive to be a trusted healthcare partner helping people maintain a healthy and active lifestyle.
The teams at BioGend Therapeutics are led by seasoned managers with team members from different functional areas. Each project is carefully planned following the phase-gate process for effective and efficient execution. For highly regulated biomedical devices, the expertise in regulatory affairs and pre-clinical and clinical development is essential in order to gain regulatory approval and to realize the potential value of innovative bio-technologies. Through developing innovative bio-orthopaedic products and establishing world class GMP processes, we hope to elevate Taiwan's biomedical industry to a new level.


RevoCart uses double-minced autologous cartilage and combines it with a bioresorbable scaffold to treat the cartilage lesion in a knee. The procedure can be done in a one-step surgery. Chondrocytes are incubated inside the patient’s knee, and no costly culture expansion of cells in vitro is needed. Minimal invasive surgery can be applied to the RevoCart procedure to shorten the recovery time. RevoCart had been launched in Taiwan market. The patients had experienced a follow-up of more than 5 years with good clinical performance.

Contact info